Intramuscular administration of 15-methyl prostaglandin F2alpha in mid-trimester termination of pregnancy.
15-methyl prostaglandin F2 alpha was administered by intramuscular injection to thirty patients to terminate pregnancy in the mid-trimester. Termination was considered successful if this occurred within 24 hours and this was so in twenty-seven cases (90%). There were no serious complications. prochlorperazine mesylate and diphenoxylate hydrochloride reduced the incidence and severity of vomiting and diarrhoea.
D000019:Abortifacient Agents / Q000008:administration & dosage*; D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage* / Q000627:therapeutic use; D000032:Abortion, Therapeutic; D000293:Adolescent; D000328:Adult; D003967:Diarrhea / Q000139:chemically induced; D015237:Dinoprost; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011460:Prostaglandins F / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D011460:Prostaglandins F; D015237:Dinoprost